- P/E Ratio
- 11.70
- Earnings
- $41.24M
- Price change (1 year)
- +34.92%
- Price change (1 day)
- -2.49%
ABDIPharmaceutical Substances and Products
Market Capitalization of Dr. Abidi Lab.
Market capitalization (market cap): 482.32 million US dollars
The latest available market capitalization of Dr. Abidi Lab. (ABDI), an Iranian listed company, is 482.32 million US dollars. Dr. Abidi Lab. ranks 34 by market capitalization among the Iranian listed companies.
Market capitalization is the market value of a listed company's outstanding shares. It measures equity value, not revenue, total assets, or enterprise value. Changes in market cap are not stock returns: they also reflect changes in share count and the exchange rate.
Dr. Abidi Lab. has the largest market capitalization in Iran's Pharmaceutical Substances and Products sector among the listed companies by this site. Dr. Abidi Lab. represents approximately 14.19% of the total market capitalization of companies in Iran's Pharmaceutical Substances and Products sector. Over the past year, the market cap of Dr. Abidi Lab. has increased by 29.82%, with 111.23 million US dollars added to its market cap. According to the Dr. Abidi Lab.’s announcement, company’s annual profit is 41.24 million US dollars. Using the latest available data, the P/E ratio of Dr. Abidi Lab. is 11.7.
Dr. Abidi Lab. Market-Cap History
The latest recorded market capitalization of Dr. Abidi Lab. was 484.17 million US dollars on 1 November 2026. Over the full period of available data, this company's market cap has increased by 1307.43%, with approximately 449.77 million US dollars added to its market cap.
Latest Market Cap by Year
| Year | Market cap | Change |
|---|---|---|
| 2026 | $484.17M | ▲ 6.57% |
| 2025 | $454.34M | ▼ 21.05% |
| 2024 | $575.45M | ▼ 28.13% |
| 2023 | $800.64M | ▲ 80.53% |
| 2022 | $443.51M | ▲ 56.44% |
| 2021 | $283.50M | ▼ 47.83% |
| 2020 | $543.41M | ▼ 4.41% |
| 2019 | $568.46M | ▲ 44.9% |
| 2018 | $392.33M | ▲ 0.35% |
| 2017 | $390.98M | ▲ 35.14% |
| 2016 | $289.30M | ▲ 409.49% |
| 2015 | $56.78M | ▲ 45.01% |
| 2014 | $39.16M | ▼ 21.02% |
| 2013 | $49.58M | ▲ 321.77% |
| 2012 | $11.75M | ▼ 64.04% |
| 2011 | $32.69M | — |
Other Companies in the Pharmaceutical Substances and Products sector
| Sector rank / Ticker / Company | Market cap | Price | Price change (1 day) |
|---|---|---|---|
| 2 DTIP Tamin Daroo | $349.15M | $0.0109 | -2.21% |
| 3 DPAK Daroupakhsh P. | $213.75M | $0.004127 | +2.71% |
| 4 DARO Daroupakhsh | $192.74M | $0.0229 | -0.96% |
| 5 FTIR Iran Parenteral | $150.31M | $0.0215 | +0.42% |
| 6 DPHZ Daana Pharma Co | $124.98M | $0.008679 | -2.58% |